{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:20:20Z","timestamp":1793132420746,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) remains a significant global health challenge, imposing substantial clinical and economic burdens. There is an urgent need to develop reliable predictive tools for early identification and intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study drew on Dryad database data to create and verify a clinical NAFLD predictive model, incorporating key parameters from 1,592 subjects randomly split into training and validation groups. We employed logistic regression on the training set to construct the model, visualized and internally validated it in R, and gauged its net benefit via decision curve analysis. The validation set underwent external assessment, with performance metrics including F1 score, precision, and recall.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The model showed strong discrimination, with an receiver operating characteristic curve area of 0.80 (95% confidence interval: 0.77\u20130.82) in training and 0.78 in validation, indicating high accuracy in NAFLD risk prediction. Calibration tests showed close alignment between predicted and actual risks, with mean absolute error values of 0.016 (training) and 0.012 (validation). Comprehensive metrics (F1 score: 0.76, precision: 0.71, recall: 0.82) reinforced its robustness and clinical value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study\u2019s results confirm the effective creation of an NAFLD predictive tool boasting high calibration accuracy and outstanding performance. Leveraging readily available clinical data, the model offers a scalable, economical approach to NAFLD, poised to pioneer a new paradigm for its precise prevention and control, and enable personalized prevention and efficient resource allocation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphys.2026.1689882","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:15:34Z","timestamp":1770880534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a high-performance clinical predictive model for early identification of non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Tong","family":"Liang","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Gansu University of Chinese Medicine","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Ren","sequence":"additional","affiliation":[{"name":"Anesthesia Operating Room, Gansu Provincial Maternity and Child-Care Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3348\/kjr.2019.0703","article-title":"Development and validation of a simple index based on non-enhanced CT and clinical factors for prediction of non-alcoholic fatty liver disease","volume":"21","author":"Ahn","year":"2020","journal-title":"Korean J. Radiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.numecd.2024.02.004","article-title":"Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: a longitudinal cohort study","volume":"34","author":"Cao","year":"2024","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/hep.32655","article-title":"Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis","volume":"77","author":"Chang","year":"2023","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/HEP.0000000000000908","article-title":"Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD","volume":"80","author":"Charu","year":"2024","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.3390\/ijms25158285","article-title":"Lipoprotein lipidomics as a frontier in non-alcoholic fatty liver disease biomarker discovery","volume":"25","author":"Herrera-Marcos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2317348","DOI":"10.1080\/07853890.2024.2317348","article-title":"LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up","volume":"56","author":"Hsu","year":"2024","journal-title":"Ann. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e46891","DOI":"10.2196\/46891","article-title":"Predicting the 5-Year risk of nonalcoholic fatty liver disease using machine learning models: prospective cohort study","volume":"25","author":"Huang","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"154010","DOI":"10.1016\/j.metabol.2019.154010","article-title":"Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: a \u201cnon-invasive alternative\u201d to liver biopsy?","volume":"101","author":"Katsiki","year":"2019","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/psp4.13052","article-title":"A markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts","volume":"12","author":"Kn\u00f6chel","year":"2023","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1038\/s41598-022-17511-6","article-title":"Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"18852","DOI":"10.1038\/s41598-024-69906-2","article-title":"Machine learning analysis of serum cholesterol's impact on knee osteoarthritis progression","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"20489","DOI":"10.1038\/s41598-023-46711-x","article-title":"Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease","volume":"13","author":"Nazari","year":"2023","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.1038\/s41598-024-59183-4","article-title":"An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis","volume":"14","author":"Njei","year":"2024","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12944-023-01966-1","article-title":"Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study","volume":"22","author":"Pan","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/ijms26062758","article-title":"Non-alcoholic fatty liver disease (NAFLD) management in the community","volume":"26","author":"Park","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e087312","DOI":"10.1136\/bmjopen-2024-087312","article-title":"Nomogram model for predicting medication adherence in patients with various mental disorders based on the dryad database","volume":"14","author":"Pei","year":"2024","journal-title":"BMJ Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1038\/s41598-023-32129-y","article-title":"Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices","volume":"13","author":"Razmpour","year":"2023","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s13018-023-04118-4","article-title":"A clinical model to predict the progression of knee osteoarthritis: data from dryad","volume":"18","author":"Shen","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12013-024-01555-8","article-title":"Long non-coding RNAs in non-alcoholic fatty liver disease; friends or foes?","volume":"83","author":"Soltanieh","year":"2025","journal-title":"Cell. Biochem. Biophys."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e101444","DOI":"10.1371\/journal.pone.0101444","article-title":"Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling","volume":"9","author":"Sowa","year":"2014","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijmm.2024.5412","article-title":"Current strategies for nonalcoholic fatty liver disease treatment","volume":"54","author":"Sun","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1111\/dom.15846","article-title":"Copper homeostasis and cuproptosis-related genes: therapeutic perspectives in non-alcoholic fatty liver disease","volume":"26","author":"Tan","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e105610","DOI":"10.1371\/journal.pone.0105610","article-title":"Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with nonalcoholic fatty liver disease","volume":"9","author":"Tarantino","year":"2014","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jgh.15385","article-title":"Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis","volume":"36","author":"Wong","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0321625","DOI":"10.1371\/journal.pone.0321625","article-title":"Association of the platelet-to-high-density lipoprotein cholesterol ratio (PHR) with metabolic syndrome and metabolic overweight\/obesity phenotypes: a study based on the dryad database","volume":"20","author":"Wu","year":"2025","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5582\/bst.2024.01295","article-title":"Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"18","author":"Xu","year":"2024","journal-title":"Biosci. Trends"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e072489","DOI":"10.1136\/bmjopen-2023-072489","article-title":"Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study","volume":"13","author":"Yan","year":"2023","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of Omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"156028","DOI":"10.1016\/j.metabol.2024.156028","article-title":"The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus","volume":"161","author":"Zeng","year":"2024","journal-title":"Metabolism"},{"key":"B34","doi-asserted-by":"publisher","first-page":"106724","DOI":"10.1016\/j.compbiomed.2023.106724","article-title":"Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies","volume":"157","author":"Zhang","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"895045","DOI":"10.3389\/fpubh.2022.895045","article-title":"A prediction model of the incidence of nonalcoholic fatty liver disease with visceral fatty obesity: a general population-based study","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Public Health"},{"key":"B36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12944-022-01748-1","article-title":"Development and validation of a new nomogram to screen for MAFLD","volume":"21","author":"Zou","year":"2022","journal-title":"Lipids Health Dis."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1689882\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:27:30Z","timestamp":1771928850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1689882\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":36,"alternative-id":["10.3389\/fphys.2026.1689882"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2026.1689882","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1689882"}}